More recently, it has also been reported that BC risk after age 50 years (but not at younger ages) was lower for women with BRCA1 pathogenic missense variants as a group, compared to those with protein termination codon variants,27 but there was no evidence for difference in OC risk between the variant types. This evidence concerns the gene BRCA1 and breast cancer.